This mdr is created as an additional follow-up to mdr record # 125050-2018-00833, initially reported on 21-nov-2018 through esubmitter.This mdr is to reflect the additional information received.According to the available information, the patient's legal representative stated severe pain with daily activities and intercourse.Altis was implanted on (b)(6) 2016 and excised on (b)(6) 2016.Corrective action: management routinely reviews events such as this and monitors complaint levels.Additionally, events of this type relating to the reported complaints are captured in the product risk documentation.Based on this, and because the device is not available for evaluation, no further corrective action is required at this time.Coloplast has not been provided any corroborating evidence to verify the information contained in this report.
|
As reported to coloplast, though not verified, additional information received on 04/23/2021.(b)(6) 2016 - erosion altis revision.(b)(6) 2016 - ongoing pelvic pain and dyspareunia s/p altis/coloplast revision, states continues to leak urine with valsalva activities, bulge has returned, states has not been the same since surgeries and is greatly affecting the quality of her life, states she desires to have altis/coloplast removed.Thick scar band (tender to palpation) in area of altis with poorly visualized area of erosion, grade 2 cystocele with loss of apical support.Urinary leakage with cough/sneeze, vaginal discharge, unable to have intercourse due to dyspareunia.Vaginal exposure of altis, pelvic pain.(b)(6) 2016 - partial excision of altis, anterior repair.Intraoperative findings: previously palpated thick scar band was contiguous with altis, most distal edge of altis found to be 4 cm from urethral meatus over lower portion of bladder, ~1 x 1 cm midline altis erosion, small amount of ecchymosis on left lateral side of bladder due to close proximity of altis.No other adverse patient effects were reported.
|